270 related articles for article (PubMed ID: 2870796)
41. Inhibition of mannose incorporation into glycoproteins and dolichol-linked intermediates of Sarcoma 180 cells by 6-methylmercaptopurine ribonucleoside.
Sokoloski JA; Sartorelli AC
Int J Cancer; 1987 Jun; 39(6):764-8. PubMed ID: 3583454
[TBL] [Abstract][Full Text] [Related]
42. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
Natsumeda Y; Yamada Y; Yamaji Y; Weber G
Biochem Biophys Res Commun; 1988 May; 153(1):321-7. PubMed ID: 2897852
[TBL] [Abstract][Full Text] [Related]
43. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
Catapano CV; Dayton JS; Mitchell BS; Fernandes DJ
Mol Pharmacol; 1995 May; 47(5):948-55. PubMed ID: 7746281
[TBL] [Abstract][Full Text] [Related]
44. Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole.
Lowe JK; Brox L; Henderson JF
Cancer Res; 1977 Mar; 37(3):736-43. PubMed ID: 837373
[TBL] [Abstract][Full Text] [Related]
45. Tiazofurin and selenazofurin induce depression of cGMP and phosphatidylinositol pathway in L1210 leukemia cells.
Parandoosh Z; Robins RK; Belei M; Rubalcava B
Biochem Biophys Res Commun; 1989 Oct; 164(2):869-74. PubMed ID: 2554903
[TBL] [Abstract][Full Text] [Related]
46. Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5'-monophosphate dehydrogenase.
Floryk D; Tollaksen SL; Giometti CS; Huberman E
Cancer Res; 2004 Dec; 64(24):9049-56. PubMed ID: 15604271
[TBL] [Abstract][Full Text] [Related]
47. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
Yamada Y; Goto H; Yoshino M; Ogasawara N
Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
[TBL] [Abstract][Full Text] [Related]
48. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
49. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
[TBL] [Abstract][Full Text] [Related]
50. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
[TBL] [Abstract][Full Text] [Related]
51. Synergistic action of tiazofurin and retinoic acid on differentiation and colony formation of HL-60 leukemia cells.
Yamaji Y; Natsumeda Y; Yamada Y; Irino S; Weber G
Life Sci; 1990; 46(6):435-42. PubMed ID: 1968220
[TBL] [Abstract][Full Text] [Related]
52. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.
Jayaram HN; Smith AL; Glazer RI; Johns DG; Cooney DA
Biochem Pharmacol; 1982 Dec; 31(23):3839-45. PubMed ID: 6130768
[TBL] [Abstract][Full Text] [Related]
53. Tiazofurin: molecular and clinical action.
Weber G; Prajda N; Abonyi M; Look KY; Tricot G
Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
[TBL] [Abstract][Full Text] [Related]
54. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses.
Huggins JW; Robins RK; Canonico PG
Antimicrob Agents Chemother; 1984 Oct; 26(4):476-80. PubMed ID: 6151377
[TBL] [Abstract][Full Text] [Related]
55. The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Cooney DA; Jayaram HN; Gebeyehu G; Betts CR; Kelley JA; Marquez VE; Johns DG
Biochem Pharmacol; 1982 Jun; 31(11):2133-6. PubMed ID: 6126195
[No Abstract] [Full Text] [Related]
56. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
Yamada Y; Natsumeda Y; Weber G
Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
[TBL] [Abstract][Full Text] [Related]
57. IMP dehydrogenase inhibitors as immunomodulators.
Mitchell BS; Dayton JS; Turka LA; Thompson CB
Ann N Y Acad Sci; 1993 Jun; 685():217-24. PubMed ID: 8103312
[TBL] [Abstract][Full Text] [Related]
58. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
[TBL] [Abstract][Full Text] [Related]
59. Modulation of acetyl-CoA carboxylase by inhibitors of IMP dehydrogenase: implications for insulin regulation.
Witters LA; Mendel DB; Colliton JW
Arch Biochem Biophys; 1987 Jan; 252(1):130-5. PubMed ID: 2880560
[TBL] [Abstract][Full Text] [Related]
60. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]